Table 6.
Type | Cells/tissues | Effects | Reference |
---|---|---|---|
In vitro research | HAECs |
Expression of VCAM-1, expression of ICAM-1, |
Chen et al., 2001 [47] |
HUVECs and HAECs | Akt phosphorylation, O bit N-acetylglucosamine amine of eNOS, 3-phosphoinositide kinase/Akt signaling pathway, expression of Nrf-2 |
Kim et al., 2010 [48] | |
HUVECs | Expression of PAI-1 Mrna. | Zhou et al., 2005 [49] | |
HUVECs | Expression of GRP78, ATF6, and the PERK-eIF2a-ATF4 pathway. |
Wu et al., 2009 [50] | |
| |||
Type | Organ/animals | Effects | Reference |
| |||
In vivo research | OLETF Diabetic rat |
Endothelial dependent vasodilation, levels of serum nitrite, serum AGEs concentration, reduce the oxidative stress. |
Kim et al., 2010 [48] |
Note: HUVEC: human umbilical vein endothelial cells; HAEC: human aortic endothelial cells; OLETF: Otsuka Long-Evans Tokushima Fatty; PAI-1: plasminogen activator inhibitor type 1; eNOS: endothelial nitric oxide synthase; VCAM-1: vascular cell adhesion molecule-1; ICAM-1: intercellular adhesion molecule 1.